Lisuride versus bromocriptine for levodopa‐induced complications in Parkinson's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Lisuride Versus Bromocriptine for Levodopa‐induced Complications in Parkinson's Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432557/all/Lisuride_versus_bromocriptine_for_levodopa‐induced_complications_in_Parkinson's_disease. Accessed 03 October 2024.
Lisuride versus bromocriptine for levodopa‐induced complications in Parkinson's disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432557/all/Lisuride_versus_bromocriptine_for_levodopa‐induced_complications_in_Parkinson's_disease. Accessed October 3, 2024.
Lisuride versus bromocriptine for levodopa‐induced complications in Parkinson's disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432557/all/Lisuride_versus_bromocriptine_for_levodopa‐induced_complications_in_Parkinson's_disease
Lisuride Versus Bromocriptine for Levodopa‐induced Complications in Parkinson's Disease [Internet]. In: Cochrane Abstracts. [cited 2024 October 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432557/all/Lisuride_versus_bromocriptine_for_levodopa‐induced_complications_in_Parkinson's_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lisuride versus bromocriptine for levodopa‐induced complications in Parkinson's disease
ID - 432557
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432557/all/Lisuride_versus_bromocriptine_for_levodopa‐induced_complications_in_Parkinson's_disease
DB - Evidence Central
DP - Unbound Medicine
ER -